Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Pulmonary hypertension (PH) is a progressive, fatal pulmonary circulatory disease that is characterized by elevated pulmonary arterial pressure and secondary right ventricular failure. PH has been reported to be highly prevalent in patients with chronic kidney disease, and especially among end-stage renal disease patients undergoing haemodialysis. However, only few data are available on drug dosage adjustment to renal function for those drugs that are commonly used in the treatment of PH. We reviewed the literature and gathered information, although sparse, to propose guidelines for using these drugs in renal insufficiency patients.


Sarah Zimner-Rapuch, Sabine Amet, Nicolas Janus, Gilbert Deray, Vincent Launay-Vacher. Pulmonary hypertension: use of oral drugs in patients with renal insufficiency. Clinical drug investigation. 2013 Jan;33(1):65-9

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 23229687

View Full Text